目的观察分析胺碘酮治疗心力衰竭合并快速型室上性心动过速的临床效果。方法 62例心力衰竭合并快速型室上性心动过速患者,按治疗方法的不同分为对照组和观察组,各31例。对照组采取西地兰治疗,观察组采取胺碘酮治疗,对两组患者的临床效果进行统计对比,并对其毒副作用进行评价。结果观察组总有效率为93.55%,高于对照组的74.19%,差异有统计学意义(P<0.05);两组患者用药前心率比较差异无统计学意义(P>0.05);观察组用药后15、60、120 min的心率均低于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率为6.45%,低于对照组的25.81%,差异有统计学意义(P<0.05)。结论心力衰竭合并快速型室上性心动过速采取胺碘酮治疗的临床效果显著,且安全性好,值得在临床中推广应用。 Objective To observe the clinical effect of amiodarone in the treatment of heart failure complicated with supraventricular tachycardia. Methods Sixty-two patients with heart failure complicated with rapid supraventricular tachycardia were divided into control group and observation group according to the different treatment methods, each of them had 31 cases. The control group was treated with cedilanid, and the observation group was treated with amiodarone. The clinical effects of the two groups were statistically compared, and their side effects were evaluated. Results The total effective rate in the observation group was 93.55%, which was higher than that in the control group (74.19%), the difference was statistically significant (P <0.05). There was no significant difference in heart rate between two groups before treatment (P> 0.05) The heart rate after 15,60,120 min was lower than that of the control group, the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 6.45%, which was lower than that of the control group (25.81%), the difference was statistically significant P <0.05). Conclusions The clinical effect of amiodarone treatment in patients with congestive heart failure complicated with supraventricular tachycardia is remarkable, and its safety is good. It is worth to be popularized in clinic.